Table 3 Distribution of cervical abnormalities at the end of follow-up&by age and hrHPV status at entry among 493 women with ASC-US from 5 sentinel screening centres in Catalonia (Spain)
AGE | |||||
|---|---|---|---|---|---|
DIAGNOSIS AT LAST FOLLOW UP& BY hrHPV STATUS | < 25 N (%) | 25-34 N (%) | 35-44 N (%) | 45-54 N (%) | > 54 N (%) |
Total N (% HPV positive)* | 84(17) 61(72.6) | 182(36.9) 101(55.5) | 100(20,3) 38(38.0) | 108(21.9) 32(29.6) | 19(3.9) 6(31.6) |
hrHPV Positive | N (%) within diagnostic category | ||||
Cancer (N = 2) | 0 | 0 | 0 | 1(50.0) | 1(50.0) |
CIN3/HSIL (N = 17) | 3(17.6) | 7(41.1) | 4(23.5) | 3(17.6) | 0(0) |
CIN2 (N = 17) | 5(29.4) | 8(47.0) | 2(11.8) | 1(5.9) | 1(5.9) |
Other milder diagnosis (N = 94) | 19(20.2) | 46(48.9) | 19(20.2) | 9(9.6) | 1(1.1) |
Normal (N = 108) | 34(31.5) | 40(37.0) | 13(12.0) | 18(16.7) | 3(2.8) |
Total (N = 238) | 61(25.6) | 101(42.4) | 38(15.9) | 32(13.4) | 6(2.5) |
hrHPV Negative | N (%) within diagnostic category | ||||
CIN 2+ (N = 1) | 0 | 0 | 1 (100) | 0 | 0 |
Other milder diagnosis (N = 35) | 7(20.0) | 10(28.6) | 9(25.7) | 9(25.7) | 0 |
Normal (N = 220) | 16(7.2) | 71(32.3) | 53(24.1) | 67(30.4) | 13(5.9) |
Total (N = 255) | 23(9.0) | 81(31.8) | 62(24.3) | 76(29.8) | 13(5.1) |